{"id":1843,"date":"2025-09-29T21:02:01","date_gmt":"2025-09-29T21:02:01","guid":{"rendered":"https:\/\/enfoca.com.mx\/?p=1843"},"modified":"2025-09-29T21:02:03","modified_gmt":"2025-09-29T21:02:03","slug":"terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10","status":"publish","type":"post","link":"https:\/\/enfoca.com.mx\/eng\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/","title":{"rendered":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10"},"content":{"rendered":"<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Samur A-I #10 Terapia G\u00e9nica en Oftalmolog\u00eda: El Futuro de la Visi\u00f3n\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/sPJ8BgYSDvY?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Terapia G\u00e9nica en Oftalmolog\u00eda: El Futuro de la Visi\u00f3n y la Optogen\u00e9tica<\/h2>\n\n\n\n<p>La oftalmolog\u00eda est\u00e1 en el umbral de una revoluci\u00f3n terap\u00e9utica impulsada por la <strong>terapia g\u00e9nica<\/strong>. Lo que antes era ciencia ficci\u00f3n, hoy es una realidad que redefine el manejo de enfermedades devastadoras. La clave para los profesionales es entender el salto de los tratamientos puntuales a las soluciones potencialmente duraderas.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h3 class=\"wp-block-heading\">Luxturna: El Punto de Partida y el Privilegio Ocular<\/h3>\n\n\n\n<p>El medicamento <strong>Luxturna (RPE65)<\/strong> demostr\u00f3 que la terapia g\u00e9nica es viable. El \u00e9xito se debe en gran parte al ojo. Es un \u00f3rgano con <strong>privilegio inmune<\/strong> y anat\u00f3micamente aislado. Esto permite la administraci\u00f3n de <strong>vectores AAV<\/strong> de manera segura y localizada.<\/p>\n\n\n\n<p>La evoluci\u00f3n m\u00e1s reciente se centra en c\u00f3mo llevar la terapia al lugar correcto. La inyecci\u00f3n <strong>intrav\u00edtrea (IBI)<\/strong> ahora es m\u00e1s efectiva. Los nuevos vectores, como la c\u00e1pside BAA2.7m8, pueden atravesar la membrana limitante interna. Esto simplifica enormemente el acceso a la retina externa, antes reservado a la cirug\u00eda subretiniana.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">El Nuevo Paradigma: Terapias Agn\u00f3sticas a la Mutaci\u00f3n<\/h3>\n\n\n\n<p>El cambio m\u00e1s radical es la llegada de terapias que funcionan sin corregir la mutaci\u00f3n original:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Optogen\u00e9tica (MCO\u2212010):<\/strong> Esta tecnolog\u00eda \u00abre-cablea\u00bb la retina. Introduce prote\u00ednas sensibles a la luz (opsinas) en c\u00e9lulas de la retina interna (como las bipolares) que sobreviven a la enfermedad. El MCO-010, que se administra por IBI, ha mostrado resultados prometedores en la <strong>Retinosis Pigmentaria<\/strong>. Los pacientes lograron ganancias significativas en agudeza visual.<\/li>\n\n\n\n<li><strong>Edici\u00f3n G\u00e9nica (CRISPR):<\/strong> Esto va m\u00e1s all\u00e1 del reemplazo g\u00e9nico. La tecnolog\u00eda CRISPR-Cas9 permite la correcci\u00f3n del <strong>ADN<\/strong> dentro del ojo. El ensayo Edit\u2212101 ha marcado un hito al reportar mejor\u00eda funcional en la amaurosis cong\u00e9nita de Leber.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">El Gran Salto: De las Enfermedades Raras a la DMAE<\/h3>\n\n\n\n<p>El enfoque se ha movido a enfermedades mucho m\u00e1s prevalentes. La <strong>DMAE h\u00fameda<\/strong> es el siguiente objetivo. Las terapias g\u00e9nicas buscan eliminar la carga de las inyecciones repetidas de anti-VEGF. La meta es una <strong>\u00fanica inyecci\u00f3n<\/strong> para producir anti-VEGF de forma continua durante a\u00f1os.<\/p>\n\n\n\n<p>El principal obst\u00e1culo para la adopci\u00f3n masiva sigue siendo el <strong>cost<\/strong>. Los modelos de precios actuales no son escalables para millones de pacientes. La comunidad global de oftalmolog\u00eda debe encontrar soluciones de fabricaci\u00f3n y financiaci\u00f3n que permitan la equidad en el acceso.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Where can you find us?<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>YouTube:<\/strong>\u00a0Subscribe to our channel for full episodes and exclusive content:\u00a0<a href=\"https:\/\/www.youtube.com\/@SamurEyePodcast\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.youtube.com\/@SamurEyePodcast<\/a><\/li>\n\n\n\n<li><strong>Instagram:<\/strong>\u00a0Follow us on Instagram for upcoming topics, guests, and highlights:\u00a0<a href=\"https:\/\/www.instagram.com\/samureyepodcast\/\" target=\"_blank\" rel=\"noreferrer noopener\">@samureyepodcast<\/a><\/li>\n<\/ul>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Terapia G\u00e9nica en Oftalmolog\u00eda: El Futuro de la Visi\u00f3n y la Optogen\u00e9tica La oftalmolog\u00eda est\u00e1 en el umbral de una [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":1844,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[188,196,192,185,194,186,195,190,187,14,174,191,193,111],"class_list":["post-1843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-samur-a-i","tag-amd-gene-therapy","tag-ciencia-y-vision","tag-crispr-cas9","tag-crispr-eye","tag-dmae-terapia-genica","tag-gene-therapy-ophthalmology","tag-luxturna","tag-mco-010","tag-ocular-gene-therapy","tag-oftalmologia","tag-oftalmologo","tag-optogenetica","tag-retinosis-pigmentaria","tag-samureye-podcast"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA<\/title>\n<meta name=\"description\" content=\"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enfoca.com.mx\/eng\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA\" \/>\n<meta property=\"og:description\" content=\"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enfoca.com.mx\/eng\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/\" \/>\n<meta property=\"og:site_name\" content=\"ENFOCA\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T21:02:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-29T21:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Riquelme\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Riquelme\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/\"},\"author\":{\"name\":\"Riquelme\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/#\\\/schema\\\/person\\\/6a00856a1ddde6dfe3a27187c99d0dad\"},\"headline\":\"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10\",\"datePublished\":\"2025-09-29T21:02:01+00:00\",\"dateModified\":\"2025-09-29T21:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/\"},\"wordCount\":482,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/enfoca.com.mx\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/SamurAI-10.png\",\"keywords\":[\"AMD Gene Therapy\",\"Ciencia y Visi\u00f3n\",\"CRISPR Cas9\",\"CRISPR Eye\",\"DMAE Terapia G\u00e9nica\",\"Gene Therapy Ophthalmology\",\"Luxturna\",\"MCO-010\",\"Ocular Gene Therapy\",\"Oftalmolog\u00eda\",\"Oftalm\u00f3logo\",\"Optogen\u00e9tica\",\"Retinosis Pigmentaria\",\"SamurEye Podcast\"],\"articleSection\":[\"Samur A-I\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/\",\"url\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/\",\"name\":\"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/enfoca.com.mx\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/SamurAI-10.png\",\"datePublished\":\"2025-09-29T21:02:01+00:00\",\"dateModified\":\"2025-09-29T21:02:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/#\\\/schema\\\/person\\\/6a00856a1ddde6dfe3a27187c99d0dad\"},\"description\":\"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#primaryimage\",\"url\":\"https:\\\/\\\/enfoca.com.mx\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/SamurAI-10.png\",\"contentUrl\":\"https:\\\/\\\/enfoca.com.mx\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/SamurAI-10.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/enfoca.com.mx\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/#website\",\"url\":\"https:\\\/\\\/enfoca.com.mx\\\/\",\"name\":\"ENFOCA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/enfoca.com.mx\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/enfoca.com.mx\\\/#\\\/schema\\\/person\\\/6a00856a1ddde6dfe3a27187c99d0dad\",\"name\":\"Riquelme\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g\",\"caption\":\"Riquelme\"},\"url\":\"https:\\\/\\\/enfoca.com.mx\\\/eng\\\/author\\\/drriquelme\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA","description":"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enfoca.com.mx\/eng\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/","og_locale":"en_US","og_type":"article","og_title":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA","og_description":"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.","og_url":"https:\/\/enfoca.com.mx\/eng\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/","og_site_name":"ENFOCA","article_published_time":"2025-09-29T21:02:01+00:00","article_modified_time":"2025-09-29T21:02:03+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png","type":"image\/png"}],"author":"Riquelme","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Riquelme","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#article","isPartOf":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/"},"author":{"name":"Riquelme","@id":"https:\/\/enfoca.com.mx\/#\/schema\/person\/6a00856a1ddde6dfe3a27187c99d0dad"},"headline":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10","datePublished":"2025-09-29T21:02:01+00:00","dateModified":"2025-09-29T21:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/"},"wordCount":482,"commentCount":0,"image":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#primaryimage"},"thumbnailUrl":"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png","keywords":["AMD Gene Therapy","Ciencia y Visi\u00f3n","CRISPR Cas9","CRISPR Eye","DMAE Terapia G\u00e9nica","Gene Therapy Ophthalmology","Luxturna","MCO-010","Ocular Gene Therapy","Oftalmolog\u00eda","Oftalm\u00f3logo","Optogen\u00e9tica","Retinosis Pigmentaria","SamurEye Podcast"],"articleSection":["Samur A-I"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/","url":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/","name":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10 - ENFOCA","isPartOf":{"@id":"https:\/\/enfoca.com.mx\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#primaryimage"},"image":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#primaryimage"},"thumbnailUrl":"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png","datePublished":"2025-09-29T21:02:01+00:00","dateModified":"2025-09-29T21:02:03+00:00","author":{"@id":"https:\/\/enfoca.com.mx\/#\/schema\/person\/6a00856a1ddde6dfe3a27187c99d0dad"},"description":"Luxturna abri\u00f3 la puerta. Ahora exploramos Optogen\u00e9tica (MCO-010) y CRISPR para corregir la DMAE y la Retinosis Pigmentaria. El futuro de la visi\u00f3n.","breadcrumb":{"@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#primaryimage","url":"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png","contentUrl":"https:\/\/enfoca.com.mx\/wp-content\/uploads\/2025\/09\/SamurAI-10.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/enfoca.com.mx\/terapia-genica-ocular-de-luxturna-a-la-optogenetica-mco-010-y-edicion-genica-crispr-samur-a-i-10\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enfoca.com.mx\/"},{"@type":"ListItem","position":2,"name":"Terapia G\u00e9nica Ocular: De Luxturna a la Optogen\u00e9tica (MCO-010) y Edici\u00f3n G\u00e9nica (CRISPR) | Samur A-I #10"}]},{"@type":"WebSite","@id":"https:\/\/enfoca.com.mx\/#website","url":"https:\/\/enfoca.com.mx\/","name":"ENFOCA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enfoca.com.mx\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/enfoca.com.mx\/#\/schema\/person\/6a00856a1ddde6dfe3a27187c99d0dad","name":"Riquelme","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3b9384ad7fa2d6e84d48469ed47a8f59d5aabb450520c89d601926a2d82ad8da?s=96&d=mm&r=g","caption":"Riquelme"},"url":"https:\/\/enfoca.com.mx\/eng\/author\/drriquelme\/"}]}},"_links":{"self":[{"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/posts\/1843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/comments?post=1843"}],"version-history":[{"count":0,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/posts\/1843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/media\/1844"}],"wp:attachment":[{"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/media?parent=1843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/categories?post=1843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enfoca.com.mx\/eng\/wp-json\/wp\/v2\/tags?post=1843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}